Distribution and frequency of tyrosine kinase inhibitor-associated long-term complications in children with chronic myeloid leukemia.
Elizabeth E DongMichael A BrunoJeffrey J KimMelanie B BernhardtAustin L BrownMaria Monica J GramatgesPublished in: Pediatric blood & cancer (2022)
TKIs have substantially improved prognosis for subsets of childhood leukemia, but there are limited long-term data to inform exposure-based risk for late-onset complications and screening. Our results suggest that TKI-exposed survivors may be at risk for long-term outcomes that extend well into survivorship.